BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23247501)

  • 1. Effect of mimetic CDK9 inhibitors on HIV-1-activated transcription.
    Van Duyne R; Guendel I; Jaworski E; Sampey G; Klase Z; Chen H; Zeng C; Kovalskyy D; El Kouni MH; Lepene B; Patanarut A; Nekhai S; Price DH; Kashanchi F
    J Mol Biol; 2013 Feb; 425(4):812-29. PubMed ID: 23247501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Tat phosphorylation on Ser-16 residue modulates HIV-1 transcription.
    Ivanov A; Lin X; Ammosova T; Ilatovskiy AV; Kumari N; Lassiter H; Afangbedji N; Niu X; Petukhov MG; Nekhai S
    Retrovirology; 2018 May; 15(1):39. PubMed ID: 29792216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA.
    Lalonde MS; Lobritz MA; Ratcliff A; Chamanian M; Athanassiou Z; Tyagi M; Wong J; Robinson JA; Karn J; Varani G; Arts EJ
    PLoS Pathog; 2011 May; 7(5):e1002038. PubMed ID: 21625572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of transcription peptide inhibitors on HIV-1 replication.
    Van Duyne R; Cardenas J; Easley R; Wu W; Kehn-Hall K; Klase Z; Mendez S; Zeng C; Chen H; Saifuddin M; Kashanchi F
    Virology; 2008 Jul; 376(2):308-22. PubMed ID: 18455747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-aided design, synthesis and validation of 2-phenylquinazolinone fragments as CDK9 inhibitors with anti-HIV-1 Tat-mediated transcription activity.
    Sancineto L; Iraci N; Massari S; Attanasio V; Corazza G; Barreca ML; Sabatini S; Manfroni G; Avanzi NR; Cecchetti V; Pannecouque C; Marcello A; Tabarrini O
    ChemMedChem; 2013 Dec; 8(12):1941-53. PubMed ID: 24150998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct inhibition of CDK9 blocks HIV-1 replication without preventing T-cell activation in primary human peripheral blood lymphocytes.
    Salerno D; Hasham MG; Marshall R; Garriga J; Tsygankov AY; Graña X
    Gene; 2007 Dec; 405(1-2):65-78. PubMed ID: 17949927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1).
    Chiu YL; Cao H; Jacque JM; Stevenson M; Rana TM
    J Virol; 2004 Mar; 78(5):2517-29. PubMed ID: 14963154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.
    Agbottah E; Deng L; Dannenberg LO; Pumfery A; Kashanchi F
    Retrovirology; 2006 Aug; 3():48. PubMed ID: 16893449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavonoid-based inhibition of cyclin-dependent kinase 9 without concomitant inhibition of histone deacetylases durably reinforces HIV latency.
    Schonhofer C; Yi J; Sciorillo A; Andrae-Marobela K; Cochrane A; Harris M; Brumme ZL; Brockman MA; Mounzer K; Hart C; Gyampoh K; Yuan Z; Montaner LJ; Tietjen I
    Biochem Pharmacol; 2021 Apr; 186():114462. PubMed ID: 33577894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the Functions of HIV-1 Tat and a Second Magnesium Ion in the CDK9/Cyclin T1 Complex: A Molecular Dynamics Simulation Study.
    Jin HX; Go ML; Yin P; Qiu XT; Zhu P; Yan XJ
    PLoS One; 2015; 10(4):e0124673. PubMed ID: 25909811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.
    Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J
    J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome.
    Sawaya BE; Khalili K; Gordon J; Taube R; Amini S
    J Biol Chem; 2000 Nov; 275(45):35209-14. PubMed ID: 10931842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of monocyte chemoattractant protein-1 (MCP-1/CCL2) gene expression by human immunodeficiency virus-1 Tat in human astrocytes is CDK9 dependent.
    Khiati A; Chaloin O; Muller S; Tardieu M; Horellou P
    J Neurovirol; 2010 Mar; 16(2):150-67. PubMed ID: 20370601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive activity between the trans-activation response RNA-binding protein, TRBP2, and cyclin T1 on HIV type 1 expression and viral production in murine cells.
    Battisti PL; Daher A; Bannwarth S; Voortman J; Peden KW; Hiscott J; Mouland AJ; Benarous R; Gatignol A
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):767-78. PubMed ID: 14585207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel, selective CDK9 inhibitors for the treatment of HIV infection.
    Németh G; Varga Z; Greff Z; Bencze G; Sipos A; Szántai-Kis C; Baska F; Gyuris A; Kelemenics K; Szathmáry Z; Minárovits J; Kéri G; Orfi L
    Curr Med Chem; 2011; 18(3):342-58. PubMed ID: 21143121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells.
    Choudhary SK; Archin NM; Margolis DM
    J Infect Dis; 2008 Apr; 197(8):1162-70. PubMed ID: 18419522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel CDK9 and Cyclin T1-associated protein complexes (CCAPs) whose siRNA depletion enhances HIV-1 Tat function.
    Ramakrishnan R; Liu H; Donahue H; Malovannaya A; Qin J; Rice AP
    Retrovirology; 2012 Oct; 9():90. PubMed ID: 23110726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent and selective inhibition of Tat-dependent HIV-1 replication in chronically infected cells by a novel naphthalene derivative JTK-101.
    Wang X; Yamataka K; Okamoto M; Ikeda S; Baba M
    Antivir Chem Chemother; 2007; 18(4):201-11. PubMed ID: 17907378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A computational study of Tat-CDK9-Cyclin binding dynamics and its implication in transcription-dependent HIV latency.
    Wang H; Song L; Zhou T; Zeng C; Jia Y; Zhao Y
    Phys Chem Chem Phys; 2020 Nov; 22(44):25474-25482. PubMed ID: 33043947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecules targeted to a non-catalytic "RVxF" binding site of protein phosphatase-1 inhibit HIV-1.
    Ammosova T; Platonov M; Yedavalli VR; Obukhov Y; Gordeuk VR; Jeang KT; Kovalskyy D; Nekhai S
    PLoS One; 2012; 7(6):e39481. PubMed ID: 22768081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.